» Authors » Lara Hoeweler

Lara Hoeweler

Explore the profile of Lara Hoeweler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 10
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Diemert D, Zumer M, Bova M, Gibbs-Tewary C, Malkin E, Campbell D, et al.
PLoS Negl Trop Dis . 2025 Jan; 18(12):e0012788. PMID: 39775205
Background: Recombinant Necator americanus Glutathione-S-Transferase-1 (Na-GST-1) formulated on Alhydrogel (Na-GST-1/Alhydrogel) is being developed to prevent anemia and other complications of N. americanus infection. Antibodies induced by vaccination with recombinant Na-GST-1...
2.
Scholte L, Leggat D, Cohen K, Hoeweler L, Erwin G, Rahaman F, et al.
STAR Protoc . 2023 Sep; 4(4):102576. PMID: 37733596
The lymph node (LN) is a critical biological site for immune maturation after vaccination as it includes several cell populations critical for priming the antibody response. Here, we present a...
3.
Diemert D, Correa-Oliveira R, Fraga C, Talles F, Silva M, Patel S, et al.
PLoS Negl Trop Dis . 2023 Mar; 17(3):e0011236. PMID: 36996185
Background: Recombinant Schistosoma mansoni Tetraspanin-2 formulated on Alhydrogel (Sm-TSP-2/Alhydrogel) is being developed to prevent intestinal and hepatic disease caused by S. mansoni. The tegumentary Sm-TSP-2 antigen was selected based on...
4.
Li G, Hoeweler L, Keegan B, Peng J, Scholte L, Hotez P, et al.
Vaccine X . 2021 Jun; 8:100100. PMID: 34169270
Introduction: As a primary stability-indicating parameter, potency should be strategically evaluated during each phase of vaccine development. Herein, we present potency testing during the early clinical development of the ()...